Business Context and Reporting Period
This Form 8-K, dated August 6, 2026, is a current report filed by RE/MAX Holdings, Inc. (REMAX) to supplement the joint proxy statement/prospectus regarding its proposed acquisition by The Real Brokerage Inc. (Real). The transaction involves the formation of a new holding company, Real REMAX Group Inc., expected to trade on the Nasdaq Global Select Market under the symbol "REAX." The transaction is anticipated to close in the second half of 2026, pending shareholder approvals scheduled for August 14, 2026.
Key Financial Metrics and Valuation
The filing provides updated financial analyses conducted by J.P. Morgan as of April 24, 2026, to support the transaction valuation. Specific historical revenue or profit figures for the current period are not included in this document; however, the following valuation metrics and assumptions are disclosed:
- Valuation Multiples (FV/2026E Adjusted EBITDA): Real (consensus) at 20.5x; REMAX (consensus) at 6.1x; Compass at 11.2x; eXp at 15.1x.
- REMAX Net Debt: Approximately $320 million as of December 31, 2025.
- Real Liquidity: Cash and equivalents of approximately $50 million as of December 31, 2025.
- Implied Equity Value (REMAX): Discounted cash flow analysis indicated a range of $10.50 to $14.00 per share, compared to an unaffected closing price of $6.56 on April 23, 2026.
- Implied Equity Value (Real): Discounted cash flow analysis indicated a range of $2.50 to $3.00 per share, compared to a closing price of $2.68 on April 24, 2026.
- Transaction Consideration: Implied offer price of $13.80 per REMAX share based on an exchange ratio of 5.150x and Real's share price of $2.68.
- Projected Synergies: Estimated present value of approximately $233 million.
Material Changes and Supplemental Disclosures
This filing serves as a voluntary supplement to the proxy statement in response to shareholder demand letters and two lawsuits filed in New York (Burke and Jones complaints) alleging disclosure deficiencies. The filing updates the following areas without admitting liability:
- Third-Party Discussions: Confirmed that on February 2, 2026, REMAX executed an NDA with "Party D" regarding a potential transaction, which included a standstill provision terminating upon REMAX entering a definitive agreement for a majority interest acquisition.
- Valuation Methodology: Clarified the specific ranges used in J.P. Morgan's discounted cash flow analyses, including perpetual growth rates (1.0% to 2.0% for REMAX; 2.0% to 3.0% for Real) and discount rates (11.0% to 12.0% for both).
- Intrinsic Value Creation: Updated analysis indicating the merger creates hypothetical incremental implied value of approximately 24.3% to REMAX shareholders.
Guidance, Outlook, and Risks
Both boards continue to unanimously recommend that shareholders vote "FOR" the transaction. The filing includes extensive forward-looking statements regarding the expected benefits, synergies, and timeline of the merger. Key risks identified include:
- Failure to obtain necessary regulatory or shareholder approvals.
- Inability to achieve projected synergies or integration challenges.
- Disruption to business operations, agent retention, and franchisee relationships.
- Potential litigation outcomes and associated costs.
- Macroeconomic factors affecting real estate markets.
Important Facts for Investor Verification
- Shareholder Vote Date: Special meetings for both Real and REMAX are scheduled for August 14, 2026.
- Post-Merger Ticker: The combined entity is expected to trade as "REAX" on the Nasdaq Global Select Market.
- Board Composition: The new Real REMAX Group Board will consist of 10 directors, with 7 classified as independent. Tamir Poleg (Real CEO) and Erik Carlson (REMAX CEO) are non-independent directors.
- Legal Challenges: Two shareholder lawsuits are pending in New York Supreme Court seeking to enjoin the transaction or seek damages; the companies deny the allegations but are providing supplemental disclosures to mitigate delay risks.
- Valuation Discrepancy: The implied offer price ($13.80) represents a significant premium over the unaffected market price ($6.56), but investors should verify the assumptions regarding the 24.3% intrinsic value creation and the $233 million synergy estimate.